Food & Health
Johnson & Johnson (JNJ.N) secured an expanded FDA approval for Imaavy on Monday, making it the first treatment cleared for warm autoimmune hemolytic anemia and broadening J&J’s autoimmune revenue base at a time when pipeline diversification is a key investor focus.
The label expansion adds...
Regenxbio (RGNX) shares fell roughly 22% on Monday after regulators placed a clinical hold on RGX-121,...
A Delaware federal court entered a $245.2 million final judgment against liquid-biopsy specialist Guardant...
Regeneron Pharmaceuticals (REGN.O) gained FDA approval Wednesday for garetosmab (Pasatru), a rare bone-disorder...
JBS, the world’s largest meatpacker, proposed Monday to acquire the roughly 18% of Pilgrim’s...
Hilleman Laboratories, a Singapore-based joint venture between Merck (MRK) and global health charity...
Nestlé (NESN.S) beat second-quarter organic sales expectations and struck a joint-venture deal with Platinum...
Trending
CATEGORIES
Categories
SIGNUP TO OUR NEWSLETTER
Subscribe
Get breaking market insights directly to your inbox